Nightingale Home Healthcare Of Florida Inc | |
550 Sw 3rd Street Suite 200, Pompano Beach, Florida 33060 | |
(954) 657-9962 | |
Name | Nightingale Home Healthcare Of Florida Inc |
---|---|
Location | 550 Sw 3rd Street Suite 200, Pompano Beach, Florida |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 107651 |
Ownership Type | Proprietary |
Service Area Zip Codes | 33021, 33026, 33027, 33029, 33060, 33062, 33063, 33064, 33065, 33066, 33067, 33068, 33069, 33071, 33073, 33077, 33309, 33313, 33314, 33321, 33322, 33324, 33327, 33330, 33331, 33332, 33351, 33441 |
NPI Number | 1174757512 |
Organization Name | NIGHTINGALE HOME HEALTHCARE OF FLORIDA, INC |
Address | 4901 Nw 17th Way, Suite 306, Ft Lauderdale, FL 33309 |
Phone Number | 317-334-7777 |
News Archive
A. Thomas McLellan, Ph.D. the top federal official on addiction treatment, chose Wiley newsletter Alcoholism & Drug Abuse Weekly for his first interview after being sworn in as deputy director of the White House Office of National Drug Control Policy. Published in the Aug. 31 issue, the interview reveals the bold directions McLellan plans to head in, including a new focus on probation and parole, in partnership with Gil Kerlikowske, ONDCP director.
For hundreds of years, people have observed that asthma severity often worsens in the nighttime. One longstanding question has been to what degree the body's internal circadian clock - as opposed to behaviors, such as sleep and physical activities - contributes to worsening of asthma severity.
Researchers at the Johns Hopkins Kimmel Cancer Center have made significant progress toward development of a simple, noninvasive liquid biopsy test that detects prostate cancer from RNA and other specific metabolic chemicals in the urine.
Insys Therapeutics, Inc. today announced that the Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for Fentanyl SL Spray. The FDA will notify Insys of its PDUFA date in the 74-day letter which is expected in the upcoming weeks.
An article published in the May 2010 issue of Postgraduate Medicine explains the benefits observational studies have in assessing clinical practice and thereby aid in improved processes of clinical care.
› Verified 1 days ago
NPI Number | 1215928742 |
Organization Name | NIGHTINGALE HOME HEALTHCARE INC |
Address | 1036 S Range Line Rd, Carmel, IN 46032 |
Phone Number | 317-334-7777 |
News Archive
A. Thomas McLellan, Ph.D. the top federal official on addiction treatment, chose Wiley newsletter Alcoholism & Drug Abuse Weekly for his first interview after being sworn in as deputy director of the White House Office of National Drug Control Policy. Published in the Aug. 31 issue, the interview reveals the bold directions McLellan plans to head in, including a new focus on probation and parole, in partnership with Gil Kerlikowske, ONDCP director.
For hundreds of years, people have observed that asthma severity often worsens in the nighttime. One longstanding question has been to what degree the body's internal circadian clock - as opposed to behaviors, such as sleep and physical activities - contributes to worsening of asthma severity.
Researchers at the Johns Hopkins Kimmel Cancer Center have made significant progress toward development of a simple, noninvasive liquid biopsy test that detects prostate cancer from RNA and other specific metabolic chemicals in the urine.
Insys Therapeutics, Inc. today announced that the Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for Fentanyl SL Spray. The FDA will notify Insys of its PDUFA date in the 74-day letter which is expected in the upcoming weeks.
An article published in the May 2010 issue of Postgraduate Medicine explains the benefits observational studies have in assessing clinical practice and thereby aid in improved processes of clinical care.
› Verified 1 days ago
NPI Number | 1649409277 |
Organization Name | NIGHTINGALE HOME HEALTHCARE OF FLORIDA INC |
Address | 550 John Knox Village Blvd, Suite 200, Pompano Beach, FL 33060 |
Phone Number | 317-334-7777 |
News Archive
A. Thomas McLellan, Ph.D. the top federal official on addiction treatment, chose Wiley newsletter Alcoholism & Drug Abuse Weekly for his first interview after being sworn in as deputy director of the White House Office of National Drug Control Policy. Published in the Aug. 31 issue, the interview reveals the bold directions McLellan plans to head in, including a new focus on probation and parole, in partnership with Gil Kerlikowske, ONDCP director.
For hundreds of years, people have observed that asthma severity often worsens in the nighttime. One longstanding question has been to what degree the body's internal circadian clock - as opposed to behaviors, such as sleep and physical activities - contributes to worsening of asthma severity.
Researchers at the Johns Hopkins Kimmel Cancer Center have made significant progress toward development of a simple, noninvasive liquid biopsy test that detects prostate cancer from RNA and other specific metabolic chemicals in the urine.
Insys Therapeutics, Inc. today announced that the Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for Fentanyl SL Spray. The FDA will notify Insys of its PDUFA date in the 74-day letter which is expected in the upcoming weeks.
An article published in the May 2010 issue of Postgraduate Medicine explains the benefits observational studies have in assessing clinical practice and thereby aid in improved processes of clinical care.
› Verified 1 days ago
Quality Rating: |
News Archive
A. Thomas McLellan, Ph.D. the top federal official on addiction treatment, chose Wiley newsletter Alcoholism & Drug Abuse Weekly for his first interview after being sworn in as deputy director of the White House Office of National Drug Control Policy. Published in the Aug. 31 issue, the interview reveals the bold directions McLellan plans to head in, including a new focus on probation and parole, in partnership with Gil Kerlikowske, ONDCP director.
For hundreds of years, people have observed that asthma severity often worsens in the nighttime. One longstanding question has been to what degree the body's internal circadian clock - as opposed to behaviors, such as sleep and physical activities - contributes to worsening of asthma severity.
Researchers at the Johns Hopkins Kimmel Cancer Center have made significant progress toward development of a simple, noninvasive liquid biopsy test that detects prostate cancer from RNA and other specific metabolic chemicals in the urine.
Insys Therapeutics, Inc. today announced that the Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for Fentanyl SL Spray. The FDA will notify Insys of its PDUFA date in the 74-day letter which is expected in the upcoming weeks.
An article published in the May 2010 issue of Postgraduate Medicine explains the benefits observational studies have in assessing clinical practice and thereby aid in improved processes of clinical care.
› Verified 1 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 98.6 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 100 | 98.6 |
How often the home health team checked patients’ risk of falling | 100 | 99.6 |
How often the home health team checked patients for depression | 100 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 87.7 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 76.2 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 100 | 96.4 |
News Archive
A. Thomas McLellan, Ph.D. the top federal official on addiction treatment, chose Wiley newsletter Alcoholism & Drug Abuse Weekly for his first interview after being sworn in as deputy director of the White House Office of National Drug Control Policy. Published in the Aug. 31 issue, the interview reveals the bold directions McLellan plans to head in, including a new focus on probation and parole, in partnership with Gil Kerlikowske, ONDCP director.
For hundreds of years, people have observed that asthma severity often worsens in the nighttime. One longstanding question has been to what degree the body's internal circadian clock - as opposed to behaviors, such as sleep and physical activities - contributes to worsening of asthma severity.
Researchers at the Johns Hopkins Kimmel Cancer Center have made significant progress toward development of a simple, noninvasive liquid biopsy test that detects prostate cancer from RNA and other specific metabolic chemicals in the urine.
Insys Therapeutics, Inc. today announced that the Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for Fentanyl SL Spray. The FDA will notify Insys of its PDUFA date in the 74-day letter which is expected in the upcoming weeks.
An article published in the May 2010 issue of Postgraduate Medicine explains the benefits observational studies have in assessing clinical practice and thereby aid in improved processes of clinical care.
› Verified 1 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 76.9 | 79.6 |
How often patients got better at getting in and out of bed | 77 | 81.1 |
How often patients got better at bathing | 77.7 | 82.3 |
How often patients’ breathing improved | 71.1 | 82.8 |
How often patients’ wounds improved or healed after an operation | - | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 65.1 | 75 |
How often home health patients had to be admitted to the hospital | 15.8 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 11.5 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 94.4 | 94 |
News Archive
A. Thomas McLellan, Ph.D. the top federal official on addiction treatment, chose Wiley newsletter Alcoholism & Drug Abuse Weekly for his first interview after being sworn in as deputy director of the White House Office of National Drug Control Policy. Published in the Aug. 31 issue, the interview reveals the bold directions McLellan plans to head in, including a new focus on probation and parole, in partnership with Gil Kerlikowske, ONDCP director.
For hundreds of years, people have observed that asthma severity often worsens in the nighttime. One longstanding question has been to what degree the body's internal circadian clock - as opposed to behaviors, such as sleep and physical activities - contributes to worsening of asthma severity.
Researchers at the Johns Hopkins Kimmel Cancer Center have made significant progress toward development of a simple, noninvasive liquid biopsy test that detects prostate cancer from RNA and other specific metabolic chemicals in the urine.
Insys Therapeutics, Inc. today announced that the Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for Fentanyl SL Spray. The FDA will notify Insys of its PDUFA date in the 74-day letter which is expected in the upcoming weeks.
An article published in the May 2010 issue of Postgraduate Medicine explains the benefits observational studies have in assessing clinical practice and thereby aid in improved processes of clinical care.
› Verified 1 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
A. Thomas McLellan, Ph.D. the top federal official on addiction treatment, chose Wiley newsletter Alcoholism & Drug Abuse Weekly for his first interview after being sworn in as deputy director of the White House Office of National Drug Control Policy. Published in the Aug. 31 issue, the interview reveals the bold directions McLellan plans to head in, including a new focus on probation and parole, in partnership with Gil Kerlikowske, ONDCP director.
For hundreds of years, people have observed that asthma severity often worsens in the nighttime. One longstanding question has been to what degree the body's internal circadian clock - as opposed to behaviors, such as sleep and physical activities - contributes to worsening of asthma severity.
Researchers at the Johns Hopkins Kimmel Cancer Center have made significant progress toward development of a simple, noninvasive liquid biopsy test that detects prostate cancer from RNA and other specific metabolic chemicals in the urine.
Insys Therapeutics, Inc. today announced that the Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for Fentanyl SL Spray. The FDA will notify Insys of its PDUFA date in the 74-day letter which is expected in the upcoming weeks.
An article published in the May 2010 issue of Postgraduate Medicine explains the benefits observational studies have in assessing clinical practice and thereby aid in improved processes of clinical care.
› Verified 1 days ago
The patient survey data of Nightingale Home Healthcare Of Florida Inc is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 83 | 88 |
Percent of patients who reported that their home health team communicated well with them | 74 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 66 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 71 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 71 | 78 |
News Archive
A. Thomas McLellan, Ph.D. the top federal official on addiction treatment, chose Wiley newsletter Alcoholism & Drug Abuse Weekly for his first interview after being sworn in as deputy director of the White House Office of National Drug Control Policy. Published in the Aug. 31 issue, the interview reveals the bold directions McLellan plans to head in, including a new focus on probation and parole, in partnership with Gil Kerlikowske, ONDCP director.
For hundreds of years, people have observed that asthma severity often worsens in the nighttime. One longstanding question has been to what degree the body's internal circadian clock - as opposed to behaviors, such as sleep and physical activities - contributes to worsening of asthma severity.
Researchers at the Johns Hopkins Kimmel Cancer Center have made significant progress toward development of a simple, noninvasive liquid biopsy test that detects prostate cancer from RNA and other specific metabolic chemicals in the urine.
Insys Therapeutics, Inc. today announced that the Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for Fentanyl SL Spray. The FDA will notify Insys of its PDUFA date in the 74-day letter which is expected in the upcoming weeks.
An article published in the May 2010 issue of Postgraduate Medicine explains the benefits observational studies have in assessing clinical practice and thereby aid in improved processes of clinical care.
› Verified 1 days ago
Nightingale Home Healthcare Of Florida Inc Location: 550 Sw 3rd Street Suite 200, Pompano Beach, Florida 33060 Ratings: Phone: (954) 657-9962 | |
Options Home Health Location: 3230 W Commercial Blvd Ste 160, Pompano Beach, Florida 33069 Ratings: Phone: (954) 598-0529 | |
Hospital Without Walls Of Broward Inc Location: 2310 Nw Third Ave Ste 8, Pompano Beach, Florida 33060 Ratings: Phone: (954) 984-8485 | |
Caring People Certified Services Location: 1000 W Mcnabb Rd Ste 211-b, Pompano Beach, Florida 33069 Ratings: Phone: (954) 861-6500 | |
Homewood Home Health, Llc Location: 3880 Coconut Creek Pkwy, Ste 202, Pompano Beach, Florida 33066 Ratings: Phone: (954) 973-3800 |